KEMIFARDA Sustained-Release Tablets 150 mg (Levamisole)

Adult dose

For adults, take 1 tablet twice a day, once in the morning and once in the evening. This medication should be swallowed whole and should not be divided or chewed.

This medicine should not be used in patients who have had hypersensitivity reactions to any of its components. Gastrointestinal discomfort may occur while taking this medication, and symptoms such as nausea, dyspepsia, and diarrhea may arise. Symptoms related to infection or musculoskeletal symptoms such as myalgia and arthralgia may also be experienced infrequently. Neurological symptoms such as dizziness and headaches have also been reported, so caution is advised. Skin reactions such as dryness, eczema, and pruritus may occur. This medication may affect liver function, so if there are symptoms of liver dysfunction, the healthcare provider should be notified immediately. Women who are pregnant or may become pregnant should only use this medication with caution if it is necessary, and nursing mothers should avoid breastfeeding during treatment. Safety in children and adolescents has not been adequately established, hence its use is not recommended in this population. Elderly patients do not have a significantly different rate of adverse reactions compared to the general population, but they may have weaker body functions, so they should be more cautious of gastrointestinal symptoms and other side effects.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor (severe allergic reactions), high fever with severe rash, blisters, skin peeling, pain in mucous membranes of the mouth/eyes (severe skin adverse reactions), shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever (respiratory problems), jaundice (yellowing of skin or eyes), extreme fatigue (liver dysfunction), sudden and severe

Mild side effects

Gastrointestinal disorders (nausea, abdominal bloating, upper abdominal pain, constipation, diarrhea, dyspepsia), infections and parasitic conditions (nasopharyngitis, epididymitis, pharyngotonsillitis), musculoskeletal and connective tissue disorders (myalgia, arthralgia), neurological disorders (dizziness, headache), skin and subcutaneous tissue disorders (skin dryness, eczema, pruritus), mental disorders (depression, insomnia), respiratory system disorders (cough, oral pharyngeal pain), hematological and lymphatic disorders (leukocyte

This medication must be stored in a tightly sealed container to protect it from air and moisture. Additionally, it should be kept at room temperature between 1 and 30 degrees Celsius and not in areas that are too hot or too cold.

Appearance

White circular sustained-release tablet

Package unit

30 tablets/bottle, 300 tablets/bottle